Relevant bibliographies by topics / Cardiac Glycosides/pharmacology

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Cardiac Glycosides/pharmacology'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cardiac Glycosides/pharmacology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cardiac Glycosides/pharmacology"

1

Heller, Michael. "Cardiac glycosides." Biochemical Pharmacology 40, no. 5 (1990): 919–25. http://dx.doi.org/10.1016/0006-2952(90)90475-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ashutosh Pathak, Priya Awasthi, Umair Ahmad, et al. "Overview Study on Characterisation Chemistry and Pharmacology of Digitalis Glycosides." Journal of Science Innovations and Nature of Earth 5, no. 1 (2025): 23–28. https://doi.org/10.59436/jsiane.302.2583-2093.

Full text
Abstract:
Medicinal plants influence human health worldwide and are an integral part of the ecology and environment. Pharmacologically, they have been used to address a number of different ailments in the past. The healing value of plants is attributed to the amount of active chemicals present in their different portions. This review aims to present a current assessment of cardiac glycosides present in African medicinal plants as potentially beneficial treatments. Google, Google Scholar, PubMed, Medline, Research Gate, Web of Sciences, ScienceDirect, and SciFinder were among the online resources used in
APA, Harvard, Vancouver, ISO, and other styles
3

Tamura, Masaaki, Hirotoshi Utsunomiya, Misa Nakamura, and Erwin J. Landon. "Effect of dietary cardiac glycosides on blood pressure regulation in rats." Canadian Journal of Physiology and Pharmacology 78, no. 7 (2000): 548–56. http://dx.doi.org/10.1139/y00-023.

Full text
Abstract:
To investigate the possible physiological significance of dietary cardiac glycosides in blood pressure regulation, the blood pressure of normal Sprague Dawley rats raised on a regular diet, which naturally contains large amounts of Na+-pump inhibitors, was compared with that of rats on a purified synthetic diet, which contains no Na+-pump specific inhibitors, and with that of rats on a synthetic diet supplemented with 10 µg·mL-1 ouabain or 10 µg·mL-1 convallatoxin in the drinking water. After 6 weeks on the synthetic diet, the systolic blood pressure in the synthetic diet group was significant
APA, Harvard, Vancouver, ISO, and other styles
4

Radford, DJ, AD Gillies, JA Hinds, and P. Duffy. "Naturally occurring cardiac glycosides." Journal of Ethnopharmacology 19, no. 3 (1987): 336–37. http://dx.doi.org/10.1016/0378-8741(87)90017-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mebs, D. "Cardiac Glycosides; Part 2: Pharmacokinetics and Clinical Pharmacology, Handbook of experimental Pharmacology." Toxicon 23, no. 2 (1985): 355. http://dx.doi.org/10.1016/0041-0101(85)90162-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dobbs, R. John, Catherine J. A. OʼNeill, Arvind A. Deshmukh, Paul W. Nicholson, and Sylvia M. Dobbs. "Serum Concentration Monitoring of Cardiac Glycosides." Clinical Pharmacokinetics 20, no. 3 (1991): 175–93. http://dx.doi.org/10.2165/00003088-199120030-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Verma, Kapil Kumar, Akanksha Sharma, Hans Raj, and Bhopesh Kumar. "A comprehensive review on traditional uses, chemical compositions and pharmacology properties of Achyranthes aspera (Amaranthaceae)." Journal of Drug Delivery and Therapeutics 11, no. 2-S (2021): 143–49. http://dx.doi.org/10.22270/jddt.v11i2-s.4789.

Full text
Abstract:
Achyranthes aspera plant is very useful for the cure and treatment of various diseases of human beings. Different parts of the plants is used to cure various diseases like leprosy, asthma, arthritis, wound, snakebite, dermatological diseases, cardiac disease, kidney stone, gynecological disorder, malaria, gonorrhea, pneumonia, dysentery, rabies, toothache, etc. Phytochemistry, pharmacological activities, diseases, traditional uses of the Achyranthes aspera may explain briefly in review articles with in-vivo and in-vitro studies. This article provided the complete latest information on the Achy
APA, Harvard, Vancouver, ISO, and other styles
8

Joubert, P. H. "Are all cardiac glycosides pharmacodynamically similar?" European Journal of Clinical Pharmacology 39, no. 4 (1990): 317–20. http://dx.doi.org/10.1007/bf00315402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Cardiac glycosides interact with many drugs." Drugs & Therapy Perspectives 6, no. 3 (1995): 11–14. http://dx.doi.org/10.2165/00042310-199506030-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Antman, Elliott M., J. Malcolm O. Arnold, Peter L. Friedman, Harvey White, Marie Bosak, and Thomas W. Smith. "Drug Interactions with Cardiac Glycosides." Journal of Cardiovascular Pharmacology 9, no. 5 (1987): 622–27. http://dx.doi.org/10.1097/00005344-198705000-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cardiac Glycosides/pharmacology"

1

McGarry, Stephen James. "The pharmacology of the sheep cardiac sarcoplasmic reticulum Ca'2'+-release channel." Thesis, Imperial College London, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.319520.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stricker, Joshua Lysle. "Protein Participants of Cytosolic Internalization of the Ouabain-bound Na+/K+ATPase Receptor in Human B-3 Lens Epithelial Cells." Wright State University / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=wright1524843508132212.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hnatowich, Mark. "Molecular pharmacology of cell receptors for cardiac glycosides, opiates, ACTH and ion channel modulators." 1987. http://hdl.handle.net/1993/24332.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Da, Costa Elodie. "Caractérisation des activités épigénétiques et anticancéreuses de la proscillaridine A dans les cancers pédiatriques." Thesis, 2019. http://hdl.handle.net/1866/24599.

Full text
Abstract:
Les glycosides cardiotoniques sont des inhibiteurs des pompes sodium / potassium utilisés pour le traitements des insuffisances cardiaques, qui détiennent également des activités anticancéreuses et épigénétiques récemment caractérisées. Toutefois, dans l’objectif de repositionner ces médicaments comme traitement anticancéreux, les mécanismes sousjacents aux activités anticancéreuses et épigénétiques des glycosides cardiotoniques restent à être déterminés. Dans nos travaux, nous révélons que la proscillaridine A est le glycoside cardiotonique qui détient des activités anticancéreuses et é
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Cardiac Glycosides/pharmacology"

1

Rietbrock, Norbert. Handbook of renal-independent cardiac glycosides: Pharmacology and clinical pharmacology. E. Horwood, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

E, Erdmann, Greeff K, and Skou J. C, eds. Cardiac glycosides 1785-1985: Biochemistry, pharmacology, clinical relevance. Steinkopff, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Greeff, K. Cardiac Glycosides : Part I: Experimental Pharmacology. Springer London, Limited, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Greeff, Kurt. Cardiac Glycosides : Part I: Experimental Pharmacology. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Greeff, Kurt. Cardiac Glycosides : Part I: Experimental Pharmacology. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Greeff, K., E. Erdmann, and J. C. Skou. Cardiac Glycosides 1785-1985: Biochemistry -- Pharmacology -- Clinical Relevance. Steinkopff, Dietrich, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dutta, S., G. Bodem, B. Bergdahl, K. E. Anderson, and H. J. Dengler. Cardiac Glycosides : Part II: Pharmacokinetics and Clinical Pharmacology. Springer London, Limited, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dutta, S., K. E. Anderson, G. Bodem, B. Bergdahl, and H. J. Dengler. Cardiac Glycosides : Part II: Pharmacokinetics and Clinical Pharmacology. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cardiac Glycosides, 1785-1985: Biochemistry, Pharmacology, Clinical Relevance (Boehringer Mannheim International Symposia). Springer-Verlag, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cardiac Glycosides : Part II: Pharmacokinetics and Clinical Pharmacology. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Cardiac Glycosides/pharmacology"

1

Soto-Blanco, Benito. "Cardiac Glycosides." In Encyclopedia of Molecular Pharmacology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-21573-6_36-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Soto-Blanco, Benito. "Cardiac Glycosides." In Encyclopedia of Molecular Pharmacology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Akera, Tai, and Theodore M. Brody. "Pharmacology of Cardiac Glycosides." In Physiology and Pathophysiology of the Heart. Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0873-7_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bhandari, Prasan. "Cardiac glycosides and treatment of cardiac failure." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals. CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Raju, SM, and AK Kapoor. "Cardiac Glycosides." In Illustrated Medical Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd., 2013. http://dx.doi.org/10.5005/jp/books/12078_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kelly, Ralph A., and Thomas W. Smith. "Endogenous Cardiac Glycosides." In Advances in Pharmacology. Elsevier, 1994. http://dx.doi.org/10.1016/s1054-3589(08)60434-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Todt, Hannes, and Harry A. Fozzard. "Chapter 25 Cardiac glycosides." In Molecular and Cellular Pharmacology. Elsevier, 1997. http://dx.doi.org/10.1016/s1569-2582(97)80050-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bhandari, Prasan. "Cardiac Glycosides and Treatment of Cardiac Failure." In Pharmacology for Medical Undergraduates. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/14244_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Udaykumar, Padmaja. "Cardiac Glycosides and Treatment of Cardiac Failure." In Pharmacology for Dental and Allied Health Sciences. Jaypee Brothers Medical Publishers (P) Ltd., 2017. http://dx.doi.org/10.5005/jp/books/12949_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Udaykumar, Padmaja. "Cardiac Glycosides and Treatment of Cardiac Failure." In Pharmacology for Dental and Allied Health Sciences. Jaypee Brothers Medical Publishers (P) Ltd., 2013. http://dx.doi.org/10.5005/jp/books/11736_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cardiac Glycosides/pharmacology"

1

Huang, Lei, Sarah Garrett Injac, Xiaonan Li, et al. "Abstract 1309: Network as a biomarker to predict drug candidates: Mapping driver dysregulated target networks onto pharmacologic data-derived drug networks identifies cardiac glycosides as the potential treatment of Group 3 medulloblastomas." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1309.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cardiac Glycosides/pharmacology' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography